Lentigen

Lentigen Corp, a division of Miltenyi Biotec, is a globally active Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of cell and gene therapy products, including lentiviral vectors and engineered T and NK cells. With over 25 years of expertise and a proven track record of manufacturing more than 700 GMP cell therapy batches, they support a wide range of clinical trials and are dedicated to advancing the availability and affordability of advanced CGT products.

The company leverages cutting-edge technology platforms to transition cell therapies from preclinical stages to commercial readiness, providing comprehensive regulatory support across more than 55 countries. Their mission focuses on enhancing the manufacturing processes of cell and gene therapies to ensure effective translation into clinical practice and market availability.

Generated from the website